According to the World Health Organization’s Global Status Report on Neurology, over 40% of the global population is living ...
The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.
The scientists found that administering the adjuvant with the vaccine yielded a two-fold increase in gut mucosal antibodies.
Support for screening does not depend on any one view of AI; the biosecurity case has long been recognized by scientists and ...
D&D‑seq uses base editing to record DNA–protein interactions in single cells, enabling multiomics mapping of transcription ...
Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing are shaping how much and where biopharmas ...
From spaceflight to high-throughput studies, evidence supports greater use of organ chips, but regulatory ambiguity and ...
Early results reveal how a single‑cell spatial platform maps stromal barriers that limit antibody delivery and target ...
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
Cellular phase separation may play a previously underappreciated role in regulating kinase activity, offering therapeutic ...
Cellares will automate the TSC-101 manufacturing and testing processes on the Cell Shuttle and the Cell Q automated testing ...
Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results